In conclusion, the use of melatonin as an adjunctive therapy for sepsis treatment significantly reduced inflammatory biomarkers and improved clinical conditions in neonates, but larger scale studies with higher validity are needed to demonstrate clear clinical benefits of the therapy 103,105,107,108,109
M.KleinR
Authors Ariana Eunjung Cha and Aaron Steckelberg refer to a Department of Veterans Affairs study, based on the data of 2.5 million patients, that found that people prescribed GLP-1 drugs had a lower relative risk of developing dementia compared with those who took other drugs for diabetes. Another study based on the medical records of over 100 million patients found that Ozempic was linked to a lower risk of cognitive problems. A study of liraglutide, an older GLP-1, found patients had slower cognitive decline than those not on the drug, and liraglutide appeared to reduce shrinkage in key parts of the brain. However, Novo Nordisk recently announced that its two clinical trials of semaglutide for dementia or mild cognitive impairment showed no cognitive benefits
*The following information, as well as all statements and products on this website, have not been evaluated by the FDA and are not intended to diagnose, mitigate, treat, cure, or prevent any disease or health condition
Serious Risks: Hormonal imbalances, insulin resistance, or allergic reactions in rare cases
When cells are supported, the body functions more efficiently as a whole
